Ondansetron (Zofran) for Gastroenteritis
Ondansetron may be given to facilitate oral rehydration in children older than 4 years and adolescents with acute gastroenteritis associated with vomiting, and can be considered in adults after adequate hydration is achieved. 1
Recommendations by Age Group
Children
- Ondansetron may be given to children >4 years of age and adolescents with acute gastroenteritis to facilitate tolerance of oral rehydration when vomiting is present 1
- Ondansetron should not be routinely used for acute gastroenteritis in children <4 years of age 1
- A single dose of ondansetron reduces vomiting episodes and decreases the need for intravenous rehydration in children with gastroenteritis 2, 3
- Dosing range of 0.13-0.26 mg/kg shows similar efficacy with no dose-dependent increase in side effects 4
Adults
- Antiemetic agents including ondansetron can be considered as ancillary treatment once the patient is adequately hydrated 1
- No specific recommendation exists for routine use of antiemetic agents for acute gastroenteritis in adults 1
Clinical Benefits of Ondansetron in Gastroenteritis
- Reduces episodes of vomiting during the acute phase 5, 2
- Facilitates oral rehydration therapy 1, 3
- Reduces the need for intravenous fluid administration 2, 6
- May reduce hospitalization rates in the immediate period 2, 3
- Can reduce emergency department length of stay 2
Important Considerations and Limitations
- Ondansetron use is not a substitute for appropriate fluid and electrolyte therapy 1
- Diarrhea has been reported as a side effect of ondansetron treatment in several studies 1, 5
- Ondansetron did not decrease hospitalization rates at 72 hours after discharge from the emergency department 1
- No significant difference in return visits to emergency departments has been observed 2, 3
- Ondansetron does not reduce the duration of diarrhea or hospital stay 6
Protocol for Use
- Ensure adequate hydration status before considering ondansetron 1
- For children >4 years: administer a single oral dose of ondansetron (0.15 mg/kg) 4, 3
- Begin oral rehydration therapy approximately 15 minutes after administration 5, 2
- Monitor for resolution of vomiting and tolerance of oral fluids 1, 2
- Consider additional doses only if necessary (evidence primarily supports single-dose efficacy) 3
Contraindications and Precautions
- Special caution in children with heart disease due to potential QT interval prolongation 1
- Not recommended as first-line therapy in pregnancy during the first trimester 1
- Should be avoided in patients with suspected inflammatory diarrhea or diarrhea with fever 1
Remember that the primary management of gastroenteritis remains adequate rehydration, with ondansetron serving as an adjunctive therapy to facilitate oral rehydration when vomiting is a significant barrier 1.